Steven Kyle Grinspoon MD
Diabetes, Lipid Metabolism
Professor of Medicine, Massachusetts General Hospital
Join to view full profile
55 Fruit StBul 457bBoston, MA 02114
Phone+1 617-726-7948
Fax+1 617-724-8998
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Grinspoon, MD is an endocrinologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and New York. He is a Professor of Medicine at Massachusetts General Hospital.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1992
University of Rochester School of Medicine and DentistryClass of 1988
Certifications & Licensure
MA State Medical License 1992 - 2028
NY State Medical License 1989 - 1992
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- 10 citationsPitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, Kathleen V Fitch, Carl J Fichtenbaum
JAMA Cardiology. 2025-03-01 - 5 citationsPitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function.Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, Jennifer A Schrack, Edgar T Overton
Clinical Infectious Diseases. 2025-02-24 - 16 citationsPerformance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leverag...Steven K Grinspoon, Markella V Zanni, Virginia A Triant, Amy Kantor, Triin Umbleja
The Lancet. HIV. 2025-02-01
Press Mentions
Even with Normal BMI, Abdominal Obesity Raises CV RiskOctober 20th, 2025- Experts Say New Obesity Definition Includes Millions More AmericansOctober 16th, 2025
- MGB Study Indicates Dramatic Increase in U.S. Adults Who Meet New Definition of ObesityOctober 15th, 2025
Grant Support
- 2025 NORC Directors MeetingMASSACHUSETTS GENERAL HOSPITAL1997–2027
- 1/2 REPRIEVE Extension for Trial CompletionMASSACHUSETTS GENERAL HOSPITAL2023–2026
